| Name | Title | Contact Details |
|---|
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Pioneering skin cancer tools for you and your family. DermaSensor is designing an affordable handheld sensor device that will let you scan your skin for irregular lesions in seconds.
Laerdal Medical Corporation maintains a national sales field team to assist customers with product information and demonstrations. Please use our contact form to request the name of your Laerdal Sales Representative.
Haupt Pharma is a Chesterfield, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cosmaceutical Research is a Surrey, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.